Complete Health Store
Complete Health Store

                              Health Talk Blog

                                                U.S.                                              California

                                   CASES               DEATHS                   CASES               DEATHS       

December 2020     19,111,443              341,149                 2,120,610               24,241


2021   Timeline

January                26,185,362              441,319                 3,310,949                40,702

February              28,602,101              513,137                 3,563,578                51,953

March                  30,459,874              552,072                 3,668,277                59,240

April                    32,225,012              574,280                 3,742,115                62,078                   

UPDATED WEEKLY - Last updated on 1 May, 2021 7:00 am PST, John Hopkins Corona Virus Dashboard and Worldometer


Cases Worldwide

                       John Hopkins                                                    Worldometer

  • TOTAL CASES      - 149,158,521                      TOTAL CASES        -   152,133,661

Recovered         -   86,527,565                        Recovered           -   129,439,543

  • TOTAL DEATHS   -    3,145,239                        TOTAL DEATHS      -      3,196,536


POPULATION - is 332,631,370 as of 1 May, 07:00 am PST, based on Census U.S. and World Population Clock.


Cases in the U.S.

  • TOTAL CASES      -   32,225,012                      TOTAL CASES         -     33,104,377

 Recovered        -                                            Recovered            -     25,710,142

  • TOTAL DEATHS   -        574,280                      TOTAL DEATHS       -          590,060


Cases in California

  • TOTAL CASES      -   3,742, 115                     TOTAL CASES          -        3,742,642

Recovered         -                                           Recovered            -       1,992,268

  • TOTAL DEATHS   -         62,078                      TOTAL DEATHS       -            61,767


2021 unemployment numbers are hovering around 8.5%.      


05/01/2021                Cases (WHO)              Deaths (WHO)                Recovered (WHO)

  • Texas**             -   2,898,949                      50,463                              2,757,365
  • Florida**            -   2,233,518                      35,172                              1,795,692
  • New York            -   2,095,597                      52,526                              1,486,644
  • Illinois                -   1,335,055                      24,291                              1,211,801
  • Pennsylvania       -   1,156,246                      26,333                              1,024,394
  • Georgia**           -   1,100,187                      20,190                                910,871
  • Ohio                   -   1,072,312                      19,284                             1,018,980
  • N. Carolina**     -      969,752                       12,651                               924,490
  • Arizona **         -      862,497                       17,324                               825,827
  • Tennessee**     -      847,430                       12,197                               822,733


          **reporting information is limited, reduced testing and increased cases




United States progress                             Updated as of 30 April 2021, 12:15 pm

  • Doses Distributed                                            308,774,155                77%
  • Doses Administered                                         240,159,677
  • 1st dose administered                                      144,894,586               44%
  • 2nd dose administered                                      93,246,540               28%
  • Total population                                              332,631,370 


State  Progress                                         Updated as of 30 April 2021, 12:15 pm

   .                                        1st dose                 2nd dose                  Population %

  • California                    30,223,491          10,863,718                    27.65
  • Alaska                            572,281               263,324                    35.72
  • Connecticut                 3,220,725            1,249,562                     34.95
  • Vermont                        579,479               208,929                     33.46
  • New York                  15,636,609            6,139,585                     31.36
  • Pennsylvania*           10,051,650            3,764,069                     29.28
  • Florida                      15,159,919            5,686,894                     27.20
  • Texas                       18,885,671            7,185,279                     25.42
  • Tennessee                 4,075,619             1,565,530                     23.33
  • Georgia                     6,306,091             2,452,194                     23.57
  • Alabama**               2,591,163             1,067,596                      21.89
  •  Correction
  • Last on vaccine tracker










In 2020, the Serum Institute of India, a manufacturer of immune-biological drugs, appeared ready to play a global role in the production of Covid-19 vaccines.  Few manufacturers can match the scale of the Institute’s facilities.


The Institute was in the forefront of efforts to combat, vaccine nationalism.”   Wealthy countries, United States, pay to secure massive numbers of doses first, while poorer countries suffer at the back of the line.


A third of the global population, in the world's poorest countries, had their hopes on India to deliver their Covid-19 vaccines. Then the virus overwhelmed India itself.  The outbreak caused widespread misery for the country's population of 1.3 billion. Hospitals are overwhelmed, oxygen is scarce and the death toll is at 200,000 – and reverberating far beyond India's borders.


The country is now prioritizing domestic supply over exports, and no longer sending scheduled doses to low and middle income countries in Africa, Asia and Latin America.  It has already exacerbated global vaccine inequality, leaving poorer countries waiting even longer which could prolong the pandemic for everyone, with the more infectious virus variants mutating.


Deciding to rely solely not just on one country — but one company in that country — was a ridiculous decision," Achal Prabhala, an Indian vaccine supply expert said.  The U.S. and other rich countries bought up most supplies of the Pfizer-BioNTech and Moderna vaccines — both expensive and delicate shots — so poorer countries turned to India.


This week India ended with another global record, daily cases crossed an unprecedented 4 lakh on Friday, while a staggering 6.9 million (69 lakh) new infections were detected in the country during April, the highest tally for any month in any country so far. 


COVID-19 Vaccine Health Center

Doses Distributed         Doses Administered

U.S.                              264,499,715                     205,871,913

California                        32,618,010                       25,569,749



J&J/Janssen, Updated Apr. 23, 2021.  U.S. Lifts Pause In Use Of J&J Vaccine After Vote By Expert Panel.  The Food and Drug Administration and the Centers for Disease Control and Prevention announced that the vaccine is safe and effective at preventing COVID-19 and its benefits outweigh the known risks. 


At Friday's meeting, the CDC said it had found a few more cases of thrombosis with thrombocytopenia syndrome, of which CVST cases are a subset. It has now identified 13 reported cases among women 18 to 49, and two cases among women 50 and older.  No cases were found among men.  This means the rate of reported cases is 7 per million shots administered among women 18 to 49.   The rate is 0.9 per million among women 50 and older.


The CDC and the FDA decided to restart administering the single-dose vaccine and to recommend that anyone with concerns should consult their health care provider.


J&J/Janssen, Updated Apr. 16, 2021.   The CDC and FDA recommended a pause in the use of Johnson & Johnson’s Janssen COVID-19 Vaccine.  With 7 million doses administered in the United States, reports of a rare and severe type of blood clot have been reported after receiving the J&J/Janssen COVID-19 Vaccine.  All reports occurred among women between 18 and 48 with symptoms occurring 6 to13 days after vaccination.  As of April 13, 2021, of the 180 million doses administered of the Pfizer-BioNTech or Moderna vaccines, no reports have been received.


If you received the vaccine:


  • more than three weeks ago, the risk of developing a blood clot is very low. 
  • within the last three weeks, the risk of developing a blood clot is very low and decreasing over time.


If you received the vaccine, seek medical care urgently if you develop any of the following symptoms:


  • severe headache,
  • backache,
  • new neurologic symptoms,
  • severe abdominal pain,
  • shortness of breath,
  • leg swelling,
  • tiny red spots on the skin, petechiae
  • new or easy bruising


WHAT DOES PAUSE MEAN?   Although the J&J/Janssen vaccine is still authorized for use, CDC and FDA recommend this vaccine not be given to anyone until we know more.  The pause gives scientists a chance to review the data and decide if recommendations on changes need to occur. 


J&J scientists refute idea that COVID-19 vaccine's design linked to clots.   Johnson & Johnson scientists refuted that the design of their COVID-19 vaccine, which is similar to the AstraZeneca vaccine, that both have been linked to a rare brain blood clot known as cerebral venous sinus thrombosis, CVST.


Six cases were reported by women in the U.S. experiencing CVST accompanied by a low blood platelet count.  The U.S. reports resemble 169 European cases with the AstraZeneca vaccine, out of 34 million doses administered there.  Both vaccine technologies use a modified version of adenoviruses, which cause the common cold, as vectors to ferry instructions to human cells. 

In a Reuter’s interview with Dr. Anthony Fauci, U.S. infectious disease expert and adviser to the White House indicated “the fact that both are adenovirus vector vaccines is an ‘obvious clue’ the cases could be linked to the vector and raises suspicion.   


Macaya Douoguih, scientist with J&J's Janssen vaccines division, the vectors used in the J&J and AstraZeneca vaccines are "substantially different."  The J&J vaccine uses a human adenovirus while the AstraZeneca vaccine uses a chimpanzee adenovirus. The vectors are also from different virologic families or species and use different cell receptors to enter cells.  The J&J vaccine shot also includes mutations to stabilize the spike protein portion of the coronavirus that the vaccine uses to produce an immune response, while the AstraZeneca vaccine does not. 


A panel of advisers to the U.S. Centers for Disease Control and Prevention are expected to meet April 23 to determine whether the pause on use of the J&J vaccine can be lifted. 


COVID-19 Vaccines and Kids: What to Know.  While the COVID-19 vaccine is available for adults, the kid version is still in clinical trials!  Do children really need one - in short, yes!

vaccine will lower the chance of serious complications and also help protect older adults around them who are high risk.  Children under 21 are 25% of the U.S. population.  If they receive the vaccine, the chance of herd immunity increases. 


Vaccine Trials for Children.   Authorization for emergency use was granted for the Pfizer COVID-19 vaccine for those 16 and older by the FDA.  The Moderna and Janssen vaccines are for those 18 and older.


Pfizer seeks FDA approval to expand COVID vaccine to ages 12 to 15.  Pfizer and BioNTech requested authorization to expand use of their coronavirus vaccine to children 12 to 15 years of age.   The request comes at a time when cases of coronavirus are rising in teens and adolescents and there is no vaccine authorized for use in those under 16.  Companies indicated the vaccine was well tolerated with side effects generally consistent with those observed in participants 16 to 25 years of age.”


Moderna Gives 1st Vaccine Shots To Young Kids As Part Of COVID-19 Study.   Children have received the first doses of Moderna's COVID-19 vaccine, as the company studies the safety and effectiveness of the vaccine for kids ages 6 months to less than 12 years old.


In the study, two injections 28 days apart of either the Moderna vaccine or a placebo will be administered.  Children will be administered one of three possible doses, from 25 micrograms to 100 micrograms.  The Moderna study will enroll 6,750 children in Canada and the U.S. - from Arizona and California to South Carolina and Texas


Johnson and Johnson.   Johnson & Johnson plans to start similar trials soon.   Once vaccines final approval for all children, distribution will probably mimic adult distribution, with higher-risk groups first.


Why Vaccines for Children Take Longer.  Children generally are not as vulnerable as adults.  It doesn’t mean children are immune to COVID-19 but simply have a lower chance of serious complications.  Another reason trials focused on adults first was speed.   Scientists need time to research children’s vaccines because their immune systems change fast.   A child’s body might respond differently to a vaccine depending on their age.  


What to expect after getting a COVID-19 vaccine


  • Learn about common side effects after getting a COVID-19 vaccine and get helpful tips how to reduce your pain and discomfort.



  • 2 weeks after the second dose of the Pfizer-BioNtech or Moderna COVID-19 vaccines and


  • 2 weeks after the single-dose J&J/Janssen COVID-19 vaccine.


  • After you are fully vaccinated against COVID-19, you may be able to return to doing some things halted prior to the pandemic.  Learn more about what you can do when you have been fully vaccinated.


WHAT CAN WE DO?   Until you are completely vaccinated, you can take basic precautions to reduce your family's risk of getting this and other illnesses by:




  • Getting recommended vaccines on schedule


  • Avoiding close contact with sick people and staying home when sick


  • Not touching the eyes, nose, or mouth with unwashed hands


  • Coughing and sneezing into a tissue, and throwing the tissue in the trash


Stay safe.  Mask.  Social distance.  Frequent hand washing.  Avoid crowds.





Write a comment


  • Barbra Rose Meyer (Tuesday, January 10 17 06:52 pm EST)

    Great blog! I left my position in brilliant hands! Very Informational!

  • Joe Felix (Sunday, December 03 17 07:06 pm EST)

    I found your COPD comments interesting. Would you consider doing a leaky gut syndrome segment?

Please enter the code
* Required fields

Store Location

Complete Health Store

1756 N. Riverside Ave
Rialto, CA 92376

Phone: 909 879-1059
Fax     : 909 879-1043



Store Hours

Monday       10 am - 5:00 pm Tuesday      10 am - 5:00 pm

Wednesday 10 am - 5:00 pm

Thursday    10 am - 5:00 pm

Friday        10 am - 5:00 pm

Saturday    10 am - 3 pm

Sunday              CLOSED




D'Lightful Bites

10:30 am - 3 pm


Phone orders are encouraged. Large orders prior to 10:30 am


Deliveries not available during covid restrictions.

Ongoing Sales!!!

Stop in to check out all the items currently discounted for your personal resolutions.



Get Social with Us

Print Print | Sitemap Recommend this page Recommend this page
© Complete Health Store